Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.01%
-0.65%
+2.17%
-0.99%
+1.57%
PRTA
Prothena Corporation
$10.54
Strengths
Upgraded on attractively valued
Chart
$9.32 (+13.09%)
$6.93 (+52.09%)
$4.59 (+129.63%)
$16.46 (-35.97%)
PRTA has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
PRTA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Revenue declined YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
PRTA Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PRTA Street view is bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
PRTA Earnings
The TTM reflects 12-month period, providing review of PRTA financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is PRTA current stock price?
What are PRTA stock strengths?
What risks are associated with PRTA stock?
When is PRTA next earnings report?
What is PRTA market cap and volume?
What is PRTA's current Stock IQ?
Should I buy PRTA stock right now?
Is PRTA a Strong Buy right now?
What does a 'Strong Buy' rating mean for PRTA?
What does a 'Strong Sell' rating mean for PRTA?
What factors influence PRTA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.01%
-0.65%
+2.17%
-0.99%
+1.57%
PRTA
Prothena Corporation
Current Price
$10.54
Stock Insights
Strengths
Upgraded on attractively valued
Chart
$9.32 (+13.09%)
$6.93 (+52.09%)
$4.59 (+129.63%)
$16.46 (-35.97%)
PRTA Analysts Opinion
PRTA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Revenue declined YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
PRTA Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PRTA Street view is bullish and have negative views on the near-term outlook
PRTA has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
PRTA Earnings
The TTM data reflects the most recent 12-month period, providing overview of PRTA financial performance.
PRTA Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
PRTA Latest Analysis
Deep Dive Into Prothena Corp Stock: Analyst Perspectives (7 Ratings). Throughout the last three months 7 analysts have evaluated Prothena Corp (NASDAQ:PRTA) offering a diverse set of opinions from ish to bearish.The following table summarizes their recent ratings shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.4210010000000001200020100Analysts provide deeper insights through their assessments of 12-month price targets revealing an aver
Tue Oct 7, 2025
HC Wainwright & Co. Maintains Prothena (PRTA) Buy Recommendation. Fintel reports that on October 7 2025 HC Wainwright &. Co. maintained coverage of Prothena (NasdaqGS:PRTA) with a Buy recommendation. Analyst Price Forecast Suggests 24.14% Upside
Tue Oct 7, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PRTA Stock trends
PRTA Stock performance
PRTA Stock analysis
PRTA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.